IcanoMAB
Pre-clinicalWe have a differentiated antibody portfolio with potential to enter clinical development for indications of high unmet medical need
Founded
2013
Focus
AntibodiesBiologics
About
We have a differentiated antibody portfolio with potential to enter clinical development for indications of high unmet medical need
Funding History
1Total raised: $5.5M
Seed$5.5MHigh-Tech GründerfondsJun 15, 2022
Company Info
TypePrivate
Founded2013
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile